Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 900,383
  • Shares Outstanding, K 31,515
  • Annual Sales, $ 108,470 K
  • Annual Income, $ -22,920 K
  • 60-Month Beta 0.91
  • Price/Sales 8.06
  • Price/Cash Flow N/A
  • Price/Book 7.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.35
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.38
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -118.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.02 +16.65%
on 01/21/20
31.46 -10.93%
on 02/13/20
+3.57 (+14.60%)
since 01/17/20
3-Month
20.64 +35.76%
on 12/12/19
31.46 -10.93%
on 02/13/20
+6.53 (+30.39%)
since 11/20/19
52-Week
14.61 +91.72%
on 10/07/19
35.87 -21.88%
on 02/26/19
-5.98 (-17.59%)
since 02/20/19

Most Recent Stories

More News
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endo Internation (ENDP , XENT , NKTR , RVNC , COLL )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

XENT : 28.34 (-0.81%)
NKTR : 23.49 (+2.85%)
Intersect Ent In is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (XENT , ITCI , RVNC , TBPH , CTLT )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

XENT : 28.34 (-0.81%)
ITCI : 25.20 (+4.96%)
RVNC : 26.88 (+0.75%)
Look for Shares of Intersect Ent In to Potentially Pullback after Yesterday's 8.50% Rise

Intersect Ent In (NASDAQ:XENT) traded in a range yesterday that spanned from a low of $26.93 to a high of $31.46. Yesterday, the shares gained 8.5%, which took the trading range above the 3-day high...

XENT : 28.34 (-0.81%)
Intersect ENT to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at the Lotte New York Palace...

XENT : 28.34 (-0.81%)
Intersect ENT to Report Fourth Quarter and Year 2019 Financial Results

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release fourth quarter and year 2019 financial...

XENT : 28.34 (-0.81%)
Intersect Ent In Shares Up 26.9% Since SmarTrend's Buy Recommendation (XENT)

SmarTrend identified an Uptrend for Intersect Ent In (NASDAQ:XENT) on November 1st, 2019 at $20.47. In approximately 3 months, Intersect Ent In has returned 26.90% as of today's recent price of $25.97....

XENT : 28.34 (-0.81%)
Intersect Ent In Set to Possibly Pullback After Yesterday's Rally of 1.24%

Intersect Ent In (NASDAQ:XENT) traded in a range yesterday that spanned from a low of $24.90 to a high of $25.39. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

XENT : 28.34 (-0.81%)
Uptrend Call Working As Intersect Ent In Stock Rises 22.3% (XENT)

SmarTrend identified an Uptrend for Intersect Ent In (NASDAQ:XENT) on November 1st, 2019 at $20.47. In approximately 3 months, Intersect Ent In has returned 22.26% as of today's recent price of $25.02....

XENT : 28.34 (-0.81%)
New Product Suite Boosts Intersect ENT Despite Cost Concerns

With respect to Intersect ENT's (XENT) Propel line, the PROPEL suite scores as the standard of care for polyp patients undergoing sinus surgery.

XENT : 28.34 (-0.81%)
MDT : 115.32 (+1.36%)
HRC : 108.32 (-0.27%)
HAE : 120.17 (-0.22%)
Intersect Ent In has the Best Relative Performance in the Pharmaceuticals Industry (XENT , HZNP , LCI , MYL , PRGO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

HZNP : 36.32 (+0.72%)
XENT : 28.34 (-0.81%)
LCI : 9.47 (+2.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade XENT with:

Business Summary

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic...

See More

Key Turning Points

2nd Resistance Point 30.18
1st Resistance Point 29.37
Last Price 28.34
1st Support Level 27.49
2nd Support Level 26.42

See More

52-Week High 35.87
Last Price 28.34
Fibonacci 61.8% 27.75
Fibonacci 50% 25.24
Fibonacci 38.2% 22.73
52-Week Low 14.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar